Zoetis Inc (ZTS)
175.14
-6.81
(-3.74%)
USD |
NYSE |
Nov 04, 16:00
175.25
+0.11
(+0.06%)
After-Hours: 20:00
Zoetis Market Cap: 79.35B for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 82.43B |
| October 31, 2024 | 81.00B |
| October 30, 2024 | 82.79B |
| October 29, 2024 | 82.12B |
| October 28, 2024 | 82.80B |
| October 25, 2024 | 81.55B |
| October 24, 2024 | 82.23B |
| October 23, 2024 | 85.62B |
| October 22, 2024 | 85.86B |
| October 21, 2024 | 85.83B |
| October 18, 2024 | 87.57B |
| October 17, 2024 | 86.53B |
| October 16, 2024 | 88.09B |
| October 15, 2024 | 87.16B |
| October 14, 2024 | 87.28B |
| October 11, 2024 | 86.12B |
| October 10, 2024 | 86.21B |
| October 09, 2024 | 86.16B |
| October 08, 2024 | 84.89B |
| October 07, 2024 | 84.85B |
| October 04, 2024 | 86.09B |
| October 03, 2024 | 86.53B |
| October 02, 2024 | 87.19B |
| October 01, 2024 | 88.08B |
| September 30, 2024 | 88.52B |
| Date | Value |
|---|---|
| September 27, 2024 | 88.26B |
| September 26, 2024 | 88.29B |
| September 25, 2024 | 86.77B |
| September 24, 2024 | 87.75B |
| September 23, 2024 | 87.71B |
| September 20, 2024 | 87.28B |
| September 19, 2024 | 87.55B |
| September 18, 2024 | 89.02B |
| September 17, 2024 | 88.67B |
| September 16, 2024 | 88.01B |
| September 13, 2024 | 86.57B |
| September 12, 2024 | 86.40B |
| September 11, 2024 | 86.08B |
| September 10, 2024 | 86.70B |
| September 09, 2024 | 86.86B |
| September 06, 2024 | 85.73B |
| September 05, 2024 | 84.53B |
| September 04, 2024 | 84.87B |
| September 03, 2024 | 83.17B |
| August 30, 2024 | 83.13B |
| August 29, 2024 | 82.86B |
| August 28, 2024 | 82.87B |
| August 27, 2024 | 82.50B |
| August 26, 2024 | 82.26B |
| August 23, 2024 | 81.96B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
44.03B
Minimum
Mar 23 2020
116.88B
Maximum
Dec 29 2021
79.46B
Average
78.68B
Median
Market Cap Benchmarks
| Pfizer Inc | 157.34B |
| Alnylam Pharmaceuticals Inc | 34.83B |
| Biomarin Pharmaceutical Inc | 12.58B |
| Corcept Therapeutics Inc | 5.246B |
| Ionis Pharmaceuticals Inc | 6.059B |
Market Cap Related Metrics
| PE Ratio | 34.27 |
| PS Ratio | 9.019 |
| PEG Ratio | 4.661 |
| Price to Book Value | 15.98 |
| Price to Free Cash Flow | 38.23 |
| Price | 175.14 |
| Earnings Yield | 2.92% |
| PEGY Ratio | 4.128 |
| Operating PE Ratio | 25.02 |
| Normalized PE Ratio | 32.17 |